International Patent: METHODS OF TREATING CANCER USING AN ANTIBODY DRUG CONJUGATE (ADC) TARGETING NECTIN-4 AND COMPRISING AN EXATECAN PAYLOAD

GENEVA, Oct. 9 -- ELI LILLY AND COMPANY filed a patent application (US2026/021851) for “METHODS OF TREATING CANCER USING AN ANTIBODY DRUG CONJUGATE (ADC) TARGETING NECTIN-4 AND COMPRISING AN EXATECAN PAYLOAD”. With publication no. WO/2026/213268, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 47/68

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....